Kraig Biocraft Laboratories Inc (KBLB) USD0.001

Sell:$0.09Buy:$0.09$0.00 (1.12%)

Prices delayed by at least 15 minutes
Sell:$0.09
Buy:$0.09
Change:$0.00 (1.12%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.09
Buy:$0.09
Change:$0.00 (1.12%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Kraig Biocraft Laboratories, Inc. develops fibers using recombinant deoxyribonucleic acid (DNA) technology for commercial applications in technical textiles. The Company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated mulberry silkworms. The Company’s products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. Its products include Monster Silk, Dragon Silk, and other products. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. The Company also focuses on developing various recombinant silks and other protein-based fibers and materials.

Key people

Kim Thompson
President, Chief Executive Officer, Chief Financial Officer, Director
Kenneth Le
Director of government relations, President of Prodigy Textiles
Jonathan R. Rice
Chief Operating Officer
Click to see more

Key facts

  • EPIC
    KBLB
  • Location
    United States
  • Sector
    Basic Materials
  • Industry
    Chemicals - Plastics & Rubber
  • ISIN
    US50075W1045
  • Market cap
    $94.42m
  • Employees
    7
  • Shares in issue
    1.04bn
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.